AnaptysBio (ANAB) Insider Trading & Ownership $22.48 +0.35 (+1.56%) As of 03:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio (NASDAQ:ANAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.50%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$928.24KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$1.39M Get ANAB Insider Trade Alerts Want to know when executives and insiders are buying or selling AnaptysBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANAB Insider Buying and Selling by Quarter AnaptysBio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/2/2025Hollings RentonDirectorSell20,925$23.57$493,202.25 1/2/2025Ecor1 Capital, LlcDirectorBuy6,646$12.95$86,065.70 12/30/2024Ecor1 Capital, LlcDirectorBuy65,184$12.92$842,177.28 9/23/2024Paul F LizzulInsiderSell1,500$38.67$58,005.00 9/16/2024Dennis MulroyCFOSell12,220$39.91$487,700.20 9/16/2024Eric J LoumeauInsiderSell8,720$39.82$347,230.40 (Data available from 1/1/2013 forward) ANAB Insider Trading Activity - Frequently Asked Questions Who is on AnaptysBio's Insider Roster? The list of insiders at AnaptysBio includes Daniel Faga, Dennis M Fenton, Dennis Mulroy, Ecor1 Capital, Llc, Eric J Loumeau, Hollings Renton, and Paul F Lizzul. Learn more on insiders at ANAB. What percentage of AnaptysBio stock is owned by insiders? 33.50% of AnaptysBio stock is owned by insiders. Learn more on ANAB's insider holdings. Which AnaptysBio insiders have been buying company stock? The following insider purchased ANAB shares in the last 24 months: Ecor1 Capital, Llc ($10,928,220.98). How much insider buying is happening at AnaptysBio? Insiders have purchased a total of 345,802 ANAB shares in the last 24 months for a total of $10,928,220.98 bought. Which AnaptysBio insiders have been selling company stock? The following insiders have sold ANAB shares in the last 24 months: Daniel Faga ($3,538,520.66), Dennis M Fenton ($45,181.50), Dennis Mulroy ($643,251.95), Eric J Loumeau ($547,481.80), Hollings Renton ($844,764.25), and Paul F Lizzul ($207,213.14). How much insider selling is happening at AnaptysBio? Insiders have sold a total of 235,752 AnaptysBio shares in the last 24 months for a total of $5,838,928.88 sold. AnaptysBio Key ExecutivesMr. Daniel R. Faga (Age 44)President, CEO & Director Compensation: $867.12kMr. Eric J. Loumeau (Age 61)Chief Legal Officer Compensation: $685.59kDr. James Newman Topper M.D. (Age 62)Ph.D., Advisor Compensation: $86.5kDr. Paul F. Lizzul FAAD (Age 49)M.B.A., M.D., M.P.H., Ph.D., Chief Medical Officer Compensation: $656.36kMr. Dennis M. Mulroy (Age 69)Chief Financial Officer Compensation: $448.81kMs. Beth MuellerSenior Vice President of Human ResourcesDr. Martin Dahl Ph.D.Senior Vice President of ResearchMr. Benjamin StoneChief Business OfficerMr. Douglas A. Rich M.B.A. (Age 55)Senior Vice President of CMC Ms. Monique Da SilvaSenior Vice President of Corporate Affairs More Insider Trading Tools from MarketBeat Related Companies CNTA Insider Ownership DNLI Insider Ownership IBRX Insider Ownership AGIO Insider Ownership IDYA Insider Ownership OCUL Insider Ownership HRMY Insider Ownership IRON Insider Ownership CGON Insider Ownership RXRX Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NASDAQ:ANAB) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
